Kardiologie / Angiologie

deFilippi and Herzog

Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease.

2017

Clinical chemistry

Apple et al.

Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care.

2017

Clinical chemistry

Chen and Burnett

Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease.

2017

Clinical chemistry

Cullen et al.

Early Rule-Out and Rule-In Strategies for Myocardial Infarction.

2017

Clinical chemistry

Dhingra and Vasan

Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

2017

Trends in cardiovascular medicine

Di Nisio et al.

Deep vein thrombosis and pulmonary embolism.

2017

Lancet (London, England)

Eggers and Lindahl

Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome.

2017

Clinical chemistry

Everett

Cardiac troponin as a novel tool for cardiovascular risk prediction in ambulatory populations.

2017

Trends in cardiovascular medicine

Giannitsis and Katus

Biomarkers for Clinical Decision-Making in the Management of Pulmonary Embolism.

2017

Clinical chemistry

Hazarika and Annex

Biomarkers and Genetics in Peripheral Artery Disease.

2017

Clinical chemistry

McGarrah et al.

A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.

2017

Clinical chemistry

Miller and Shyy

Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation.

2017

Trends in endocrinology and metabolism: TEM

Omland and White

State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease.

2017

Clinical chemistry

Sandoval and Thygesen

Myocardial Infarction Type 2 and Myocardial Injury.

2017

Clinical chemistry

Tricoci

Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention.

2017

Clinical chemistry

Vasile and Jaffe

Natriuretic Peptides and Analytical Barriers.

2017

Clinical chemistry

Walsh and Cook

Issues and Challenges in Diagnostic Sequencing for Inherited Cardiac Conditions.

2017

Clinical chemistry

Wollert et al.

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.

2017

Clinical chemistry

Akyol et al.

Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.

2016

Clinica chimica acta; international journal of clinical chemistry

Beneke et al.

Differenzierung thrombotischer Mikroangiopathien

2016

Der Nephrologe

Bindu et al.

Role of Sirtuins in Regulating Pathophysiology of the Heart.

2016

Trends in endocrinology and metabolism: TEM

Cahill and Prendergast

Infective endocarditis.

2016

Lancet

Cogswell et al.

Dietary Sodium and Cardiovascular Disease Risk – Measurement Matters.

2016

The New England journal of medicine

Evstatiev

Eisenmangel, Thrombozytose und Thromboembolie

2016

Wiener Medizinische Wochenschrift

Gao et al.

Functional regulatory roles of microRNAs in atherosclerosis.

2016

Clinica chimica acta; international journal of clinical chemistry

Gladwin

Cardiovascular complications and risk of death in sickle-cell disease.

2016

Lancet (London, England)

Grundy

Metabolic syndrome update.

2016

Trends Cardiovasc Med

Hai and Zuo

Aberrant DNA methylation in the pathogenesis of atherosclerosis.

2016

Clin Chim Acta

Horvatits et al.

Hepatokardiale Wechselwirkungen

2016

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Janssens and Joannidis

Akute kardiorenale Syndrome

2016

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Jin et al.

Apoprotein C-III: A review of its clinical implications.

2016

Clinica chimica acta; international journal of clinical chemistry

Koskinas et al.

Regression of coronary atherosclerosis: Current evidence and future perspectives.

2016

Trends Cardiovasc Med

Kotani et al.

Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions.

2016

Critical reviews in clinical laboratory sciences

Laux et al.

A medical-toxicological view of tattooing.

2016

Lancet

Lazo et al.

Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.

2016

Clinical chemistry

Manrai et al.

Genetic Misdiagnoses and the Potential for Health Disparities.

2016

The New England journal of medicine

Mizamtsidi et al.

Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?

2016

European journal of clinical investigation

Mulay and Anders

Crystallopathies.

2016

N Engl J Med

Myles et al.

Stopping vs. Continuing Aspirin before Coronary Artery Surgery.

2016

N Engl J Med

Nioi et al.

Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.

2016

N Engl J Med

Nordestgaard et al.

Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.

2016

Clinical chemistry

O'Neill et al.

Blood-Based Biomarkers for Metabolic Syndrome.

2016

Trends Endocrinol Metab

O'Shea et al.

Hypertension: The role of biochemistry in the diagnosis and management.

2016

Clinica chimica acta; international journal of clinical chemistry

Park-Windhol and D'Amore

Disorders of Vascular Permeability.

2016

Annu Rev Pathol

Pfeffer and McMurray

Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.

2016

The New England journal of medicine

Pownall and Gotto

New Insights into the High-Density Lipoprotein Dilemma.

2016

Trends Endocrinol Metab

Santos et al.

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.

2016

The lancet. Diabetes & endocrinology

Schefold et al.

Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

2016

Nature reviews. Nephrology

Stancel et al.

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.

2016

Clin Chem

Strotmann and Wolpert

Antikoagulation und perioperatives Bridging

2016

Der Kardiologe

Tybjærg-Hansen

The Sialylation Pathway and Coronary Artery Disease.

2016

N Engl J Med

Wang

Vitamin D and Cardiovascular Disease.

2016

Annu Rev Med

Wanner et al.

The heart and vascular system in dialysis.

2016

Lancet (London, England)

Wechalekar et al.

Systemic amyloidosis.

2016

Lancet (London, England)

Zhong et al.

Sortilin: A novel regulator in lipid metabolism and atherogenesis.

2016

Clinica chimica acta; international journal of clinical chemistry

Anwar et al.

Elevation of cardiovascular risk by non-steroidal anti-inflammatory drugs.

2015

Trends Cardiovasc Med

Buglioni and Burnett

Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.

2015

Clin Chim Acta

Clerico et al.

Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides.

2015

Clin Chim Acta

Cozzolino

New endocrine biomarkers and cardiovascular disease: is it time for routinely screening?

2015

Clin Chem Lab Med

Dokmanovic and Wu

Monitoring Trastuzumab Resistance and Cardiotoxicity: A Tale of Personalized Medicine.

2015

Advances in Clinical Chemistry

Dzeshka and Lip

Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?

2015

Trends Cardiovasc Med

Eren et al.

HDL functionality and crystal-based sterile inflammation in atherosclerosis.

2015

Clin Chim Acta

Evrard et al.

Vascular calcification: from pathophysiology to biomarkers.

2015

Clin Chim Acta

Fernandes and Valdes

Cardiovascular disease and osteoarthritis: common pathways and patient outcomes.

2015

Eur J Clin Invest

Gulati and Merz

New cholesterol guidelines and primary prevention in women.

2015

Trends Cardiovasc Med

Herder et al.

The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.

2015

Trends Endocrinol Metab

Kobayashi and Mabuchi

Lipoprotein lipase and atherosclerosis.

2015

Annals of clinical biochemistry

Kutkut et al.

Lymphatic vessels: an emerging actor in atherosclerotic plaque development.

2015

Eur J Clin Invest

Lavandero et al.

Autophagy in cardiovascular biology.

2015

J Clin Invest

Luo et al.

Cystatin C and cardiovascular or all-cause mortality risk in the general population: A meta-analysis.

2015

Clin Chim Acta

Ma and Li

SIRT1: role in cardiovascular biology.

2015

Clin Chim Acta

Mahajan et al.

Impact of obesity on cardiac metabolism, fibrosis, and function.

2015

Trends Cardiovasc Med

Manousopoulou et al.

Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis.

2015

Eur J Clin Invest

Massy and Drüeke

Magnesium and cardiovascular complications of chronic kidney disease.

2015

Nat Rev Nephrol

Matsushita et al.

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

2015

Lancet Diabetes Endocrinol

Mehta et al.

Ischemic heart disease in women: a focus on risk factors.

2015

Trends Cardiovasc Med

Min and Chan

The biology of circulating microRNAs in cardiovascular disease.

2015

Eur J Clin Invest

O'Hare et al.

Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.

2015

Expert Rev Cardiovasc Ther

Opie

Present status of statin therapy.

2015

Trends Cardiovasc Med

Pouleur

Which biomarkers do clinicians need for diagnosis and management of heart failure with reduced ejection fraction?

2015

Clin Chim Acta

Poulter et al.

Hypertension.

2015

Lancet

Rabelink and de Zeeuw

The glycocalyx – linking albuminuria with renal and cardiovascular disease.

2015

Nat Rev Nephrol

Roberts

A genetic basis for coronary artery disease.

2015

Trends Cardiovasc Med

Rungoe et al.

Inflammatory bowel disease and risk of coronary heart disease.

2015

Trends Cardiovasc Med

Saleheen et al.

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.

2015

Lancet Diabetes Endocrinol

Salerni et al.

The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens.

2015

Eur J Clin Invest

Sedaghat-Hamedani et al.

Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury – a metaanalysis of 45 studies.

2015

Clin Chem

da Silva et al.

Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.

2015

Eur J Clin Invest

Stankowski et al.

Cardiovascular consequences of cocaine use.

2015

Trends Cardiovasc Med

van Tienhoven-Wind and Dullaart

Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders.

2015

Eur J Clin Invest

Timmis

Acute coronary syndromes.

2015

BMJ (Clinical research ed.)

Torre and Jarolim

Cardiac troponin assays in the management of heart failure.

2015

Clin Chim Acta

Xiong et al.

Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation.

2015

Expert Opin Drug Metab Toxicol